Ikarian Capital’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-180
Closed 177
2022
Q2
$0 Sell
180
-218,358
-100% -$455K ﹤0.01% 224
2022
Q1
$525K Buy
218,538
+10,232
+5% +$21.7K 0.07% 137
2021
Q4
$433K Hold
208,306
0.06% 134
2021
Q3
$399K Sell
208,306
-3,165
-1% -$5.37K 0.03% 190
2021
Q2
$472K Buy
+211,471
New +$489K 0.04% 188
2021
Q1
Sell
-259,337
Closed -$1.68M 339
2020
Q4
$1.68M Sell
259,337
-175,449
-40% -$797K 0.07% 163
2020
Q3
$1.76M Sell
434,786
-632,485
-59% -$2.38M 0.13% 114
2020
Q2
$3.86M Sell
1,067,271
-300,000
-22% -$781K 0.31% 76
2020
Q1
$2.69M Buy
1,367,271
+300,000
+28% +$925K 0.2% 84
2019
Q4
$4.09M Buy
+1,067,271
New +$2.61M 0.66% 42

Other funds holding OTIC

Ikarian Capital's OTIC Position: Q3 2022 in Review

Ikarian Capital sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 180 shares.

Ikarian Capital first reported a position in OTIC in Q4 2019 and held it in 10 quarters. The position peaked at $4.09M in Q4 2019. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • Ikarian Capital reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 180 Otonomy, Inc. shares in Q3 2022.
  • Ikarian Capital first reported a position in Otonomy, Inc. in Q4 2019 and held it in 10 quarters.
  • Ikarian Capital's Otonomy, Inc. position peaked at $4.09M in Q4 2019.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.